Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Poliomyelitis: present epidemiological situation and vaccination problems.

× No keyword cloud information.

26 in total

Review 1. Polio vaccines: time for a change in immunisation policy?

Authors: A J Beale
Journal: Lancet Date: 1990-04-07 Impact factor: 79.321

2. Serum antibodies to polioviruses in a Tuscan population, Italy.

Authors: D Reali; A Carducci; M A Ruschi
Journal: Eur J Epidemiol Date: 1990-09 Impact factor: 8.082

3. Response to trivalent oral poliovirus vaccine with and without immune serum globulin in young adults in Israel in 1988.

Authors: M S Green; J L Melnick; D Cohen; R Slepon; Y L Danon
Journal: J Infect Dis Date: 1990-10 Impact factor: 5.226

4. Antipoliomyelitis immunity status in a cohort of young men drafted into military service, residing in the suburban Milan area.

Authors: A Pianetti; L Salvaggio; M R Biffi; W Baffone; F Bruscolini; S de Donato; A Albano
Journal: Eur J Epidemiol Date: 1997-09 Impact factor: 8.082

5. Outbreak of paralytic poliomyelitis in Oman: evidence for widespread transmission among fully vaccinated children.

Authors: R W Sutter; P A Patriarca; S Brogan; P G Malankar; M A Pallansch; O M Kew; A G Bass; S L Cochi; J P Alexander; D B Hall
Journal: Lancet Date: 1991-09-21 Impact factor: 79.321

6. Serum antibodies to poliomyelitis in Italy.

Authors: R Santoro; F Lombardi; F Novello; C Amato; F M Ruggeri; M E Grandolfo; I Annesi; C M Cortellessa; F Timperi; R Inglese
Journal: Bull World Health Organ Date: 1984 Impact factor: 9.408

7. Importation of poliomyelitis to industrialised nations between 1975 and 1984: evaluation and conclusions for vaccination recommendations.

Authors: D Kubli; R Steffen; M Schär
Journal: Br Med J (Clin Res Ed) Date: 1987-07-18

Review 8. Rationale for the sequential use of inactivated poliovirus vaccine and live attenuated poliovirus vaccine for routine poliomyelitis immunization in the United States.

Authors: A M McBean; J F Modlin
Journal: Pediatr Infect Dis J Date: 1987-10 Impact factor: 2.129

9. Antibodies to polioviruses in an Israeli population and overseas volunteers.

Authors: M Margalith; A Morag; B Fattal
Journal: J Med Virol Date: 1990-01 Impact factor: 2.327

10. Randomised trial of alternative formulations of oral poliovaccine in Brazil.

Authors: P A Patriarca; F Laender; G Palmeira; M J Oliveira; J Lima Filho; M C Dantes; M T Cordeiro; J B Risi; W A Orenstein
Journal: Lancet Date: 1988-02-27 Impact factor: 79.321

1 in total

1. Maximal adjuvant activity of nasally delivered IL-1α requires adjuvant-responsive CD11c(+) cells and does not correlate with adjuvant-induced in vivo cytokine production.

Authors: Afton L Thompson; Brandi T Johnson; Gregory D Sempowski; Michael D Gunn; Baidong Hou; Anthony L DeFranco; Herman F Staats
Journal: J Immunol Date: 2012-02-15 Impact factor: 5.422

1 in total